WFDC12 and psoriasis: In the next step, we will use Th1 cytokine blockers or retinoic acid signal pathway modulators to observe whether the severity of psoriatic lesions in mice is improved after treatment, so as to further clarify the role of WFDC12 in the pathogenesis of psoriasis.